Bio Special BioInvest

Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results

Fourth-quarter fiscal year 2022 Revenue of $1.85 billion represents 11% reported growth year-over-year; and up 17% on a core(1) basis. GAAP net in...

 November 24, 2022 | News

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM Irvine Scientific Triples the company’s current capacity for liquid cel...

 November 23, 2022 | News

GE Announces Closing of Offering of $8.25 Billion Senior Notes issued by GE HealthCare

The Notes were offered as part of the financing for the proposed spin-off of GE HealthCare from GE (the “Spin-Off”), which is expected to be co...

 November 23, 2022 | News

Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines

Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives fo...

 November 15, 2022 | News

Merck Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3

Results of the third quarter of 2022 Group net sales rise by 16.8% to € 5.8 billion Strong organic sales growth of 7.1%, driven by the &...

 November 14, 2022 | News

Orgenesis Secures up to $50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services

 Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potent...

 November 08, 2022 | News

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

 Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its me...

 November 02, 2022 | News

LAXAI Receives Investment from SIGNET Healthcare Partners

LAXAI Inc. (“LAXAI”) announced today that it has received a growth capital investment from SIGNET Healthcare Partners (“SIGNET”), a...

 October 25, 2022 | News

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement

Sumitovant Biopharma Ltd. ("Sumitovant"), in conjunction with parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma"), and Myovant Sciences ("Myovant"...

 October 24, 2022 | News

MedAlliance to be Acquired by Cordis

Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies.  MedAlliance's innov...

 October 19, 2022 | News

Kupando Raises €13 Million in Series A Funding Round

 Kupando, a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious disease...

 September 27, 2022 | News

Redbud raises $10M in series A round as CRO focusing on science-driven clinical development

Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...

 September 13, 2022 | News

Breast Cancer AI Company FathomX Raises SGD$ 2.24 million in Pre-series A Funding

Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images including mammograms. The fu...

 September 02, 2022 | News

Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation

Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership th...

 August 30, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in